Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?

被引:21
|
作者
Singh, Shivaram Prasad [1 ]
Misra, Bijay [1 ]
Kar, Sanjib Kumar [1 ]
Panigrahi, Manas Kumar [1 ]
Misra, Debasis [1 ]
Bhuyan, Pallavi [2 ]
Pattnaik, Kaumudee [2 ]
Meher, Chudamani [3 ]
Agrawal, Omprakash [3 ]
Rout, Niranjan [4 ]
Swain, Manorama [5 ]
机构
[1] SCB Med Coll, Dept Gastroenterol, Cuttack 753007, Orissa, India
[2] SCB Med Coll, Dept Pathol, Cuttack 753007, Orissa, India
[3] Beam Diagnost Ctr, Dept Radiol, Cuttack 753001, Orissa, India
[4] AH Reg Canc Ctr, Dept Oncopathol, Cuttack 753001, Orissa, India
[5] SCB Med Coll, Dept Biochem, Cuttack 753007, Orissa, India
关键词
BETA-CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT; CRYPTOGENIC CIRRHOSIS; NATURAL-HISTORY; STEATOHEPATITIS; ASSOCIATION; PREVALENCE; POPULATION; GLUCOSE; IMPACT;
D O I
10.1016/j.clinre.2014.08.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Nonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of insulin resistance [IR]. However, a significant proportion of NAFLD patients are devoid of IR. Is NAFLD sans IR a different entity? The aim of the study was to compare the anthropometric, metabolic, biochemical, ultrasonography, and histological profile of NAFLD patients with and without IR. Methods: Retrospective analyses of 336 NAFLD patients diagnosed during the last two years was done. Patients without IR were compared with those with IR. Results: Out of 336 patients, 153 [45.53%] were without IR. Although age, gender, BMI and transaminase levels were comparable, significantly higher proportion of patients in non-IR group were non-obese [43.14% vs. 25/14%; P = 0.0005], and had mild fatty change on ultrasonography; [78.43% vs. 67.21%; P = 0.022]. Higher proportion of them had elevated transaminases; [67.97% vs. 56.83%; P = 0.036]. Serum triglyceride [178.52 +/- 78.78 vs. 204.86 +/- 94.72 mg/dl; P = 0.02], FBG [85.39 +/- 13.80 vs. 98.93 +/- 31.56 mg/dl; P = 0.00], PGBG [123.76 +/- 36.77 vs. 148.07 +/- 64.67 mg/dl; P = 0.00], and serum insulin [6.33 +/- 2.18 vs. 15.39 +/- 12.56 +/- IU/ml; P = 0.00] were significantly lower in patients without IR. Although there was no difference in histology, interestingly fibrosis was seen in one third of patients despite absence of IR. Conclusion: Nearly half of our NAFLD population was without IR; one third of them had significant fibrosis. NAFLD is probably a heterogeneous disease and IR is not the sole factor responsible for NAFLD; further studies are needed to find out other possible etiological factors. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:482 / 488
页数:7
相关论文
共 50 条
  • [31] Die nichtalkoholische Fettlebererkrankung (NAFLD)Nonalcoholic fatty liver disease (NAFLD)
    S. Zeuzem
    C. Trautwein
    Der Gastroenterologe, 2020, 15 (2): : 77 - 77
  • [32] A Comparative Study of Effect of Insulin Sensitizers and Statins in Nonalcoholic Fatty Liver Disease (NAFLD)
    Siddique, Kauser U.
    Reddy, Himanshu
    Rana, Himanshu
    Singhal, Shubham
    Parihar, Anit
    Pandey, Alok
    DIABETES, 2015, 64 : A661 - A661
  • [33] Does Nonalcoholic Fatty Liver Disease (NAFLD) Develop in Insulin-Sensitive Patients?
    Bril, Fernando
    Lomonaco, Romina
    Sanchez, Paola Portillo
    Orsak, Beverly
    Maximos, Maryann
    Finch, Joan
    Webb, Amy
    Cusi, Kenneth
    DIABETES, 2014, 63 : A465 - A465
  • [34] Noninvasive Diagnostics in Nonalcoholic Fatty Liver Disease (NAFLD)
    Stauber R.
    Journal für Gastroenterologische und Hepatologische Erkrankungen, 2019, 17 (3) : 75 - 81
  • [35] An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)
    Lomonaco, Romina
    Chen, Janet
    Cusi, Kenneth
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2011, 2 (05) : 211 - 225
  • [36] Developmental Origins of Nonalcoholic Fatty Liver Disease (NAFLD)
    Itoh, Hiroaki
    Kanayama, Naohiro
    DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD): FROM BIOLOGICAL BASIS TO CLINICAL SIGNIFICANCE, 2018, 1012 : 29 - 39
  • [37] Vitamin E and nonalcoholic fatty liver disease (NAFLD)
    Thakur, Varsha
    Ulatowski, Lynn
    Parker, Robert
    Zhang, Renliang
    Liu, Xiuli
    Manor, Danny
    FASEB JOURNAL, 2013, 27
  • [38] Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)
    Boudaoud, Amel Ait
    Rives-Lange, Claire
    Perregaux, Jean Francois
    Radu, Alina
    Messager-Josipowicz, Diane
    Barsamian, Charles
    Carette, Claire
    Czernichow, Sebastien
    PRESSE MEDICALE, 2019, 48 (12): : 1496 - 1501
  • [39] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [40] Characteristics of Patients with Type 2 Diabetes without Nonalcoholic Fatty Liver Disease (NAFLD)
    Saenz, Enrique Valdez
    Leiva, Eddison Godinez
    Lomonaco, Romina
    Marangi, Stephen A.
    Kalavalapalli, Srilaxmi
    Gonzalez, Maria A.
    Chi, Xiaofei
    Rocha, Andrea Ortiz
    Mohseni, Yasmine
    Barb, Diana
    Gurka, Matthew J.
    Sharma, Anu
    Cusi, Kenneth
    DIABETES, 2023, 72